Business Standard

Decoded: How WHO's mRNA Tech Transfer Hub is working for vaccine access

After examining several proposals from India, Hyderabad-based Biological E has now been selected to partner with WHO to make mRNA technology-based vaccines in the country

vaccine
Premium

Sohini Das Mumbai
Concerned that low- and medium-income countries would be left behind in access to Covid-19 vaccines, the World Health Organisation (WHO) came up with the idea of setting up an mRNA Technology Transfer Hub in South Africa. While the hub will develop the mRNA Covid vaccine, several centres (or “spokes”, as they have been termed) across the globe would have access to the technology and the know-how to make the vaccine locally. After examining several proposals from India, Hyderabad-based Biological E has now been selected to partner with WHO to make mRNA technology-based vaccines in the country as part of the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in